-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Parvovirus B 19 was discovered at the Virus Reference Laboratory in 1975 by Cossart and colleagues (
1
). First found in healthy blood donors, parvovirus B19 infection usually manifests as erythema infectiosum (fifth disease) in children. In adults the infection can cause acute arthritis. The virus replicates in erythroid progenitors, and patients with an underlying hemolytic anemia can experience a transient aplastic crisis. Anaemia may occur in immunocompromised patients due to persistent B19 infection and this can be treated with immunoglobulin. Infection during pregnancy can result in fetal anemia, hydrops fetalis, and intrauterine death.